| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Hanjie Zheng CEO | XSHE Exchange | CNE1000058X0 ISIN |
| CN Country | 1,081 Employees | 1 Jun 2026 Last Dividend | 1 Jun 2026 Last Split | - IPO Date |
Guangdong Taienkang Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, engaging in various activities related to the research, development, production, and sale of pharmaceutical products. Operating both within China and internationally, this company offers a wide range of therapeutic products and medical supplies. Founded in 1999 and initially known as Shantou Taikang Pharmaceutical Co., Ltd., the company underwent a name change in June 2006 to better reflect its geographical base and expansion. Headquartered in Shantou, China, Guangdong Taienkang Pharmaceutical Co., Ltd. has grown to provide not only pharmaceutical products but also medical technology services, technology transfer services, and act as an agent for pharmaceutical products.